Related Experiment Video
Updated: May 16, 2025
09:25
Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
Published on: May 24, 2020
5.2K
Smallpox Vaccines for Monkeypox: Is Emergency Vaccination Imminent?
Syed Mukareem Ali1, Khabab Abbasher Hussien Mohamed Ahmed2, Areeba Ahsan3
1Dow University of Health Sciences, Karachi, Pakistan.
Disaster Medicine and Public Health Preparedness
|April 2, 2025
Summary
Monkeypox virus (MPXV) is a contagious disease endemic since 1970. Research is needed to assess vaccine safety, immunity duration, and efficacy against MPXV strains, considering viral mutation and animal transmission complexities.
Area of Science:
- Epidemiology
- Virology
- Public Health
Background:
- Monkeypox virus (MPXV) has been endemic in parts of Africa since 1970.
- MPXV infection presents with symptoms including fever, headache, and rash.
- While smallpox vaccination may offer cross-protection, MPXV eradication is complicated by animal reservoirs.
Purpose of the Study:
- To highlight the need for research into MPXV vaccine safety, duration of immunity, and efficacy.
- To address the challenges posed by MPXV's mutation rate and zoonotic transmission.
- To advocate for a global immunization strategy informed by past eradication efforts.
Main Methods:
- Literature review on MPXV epidemiology and transmission.
- Analysis of existing vaccination data for smallpox and MPXV.
- Assessment of viral mutation rates and zoonotic factors.
Main Results:
- Vaccination is effective in limiting MPXV transmission.
- MPXV's dependence on animal hosts complicates eradication efforts.
- Accelerated viral mutation and zoonotic transmission present significant challenges.
Conclusions:
- Further research is crucial to optimize MPXV vaccines.
- A comprehensive global immunization strategy is essential for controlling MPXV.
- Lessons from smallpox eradication should inform MPXV control efforts.
